Miriam Thomas, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 35 Green Pond Rd, Suite A, Rockaway, NJ 07866 Phone: 973-627-6010 Fax: 973-625-9424 |
News Archive
Small pieces of nucleic acid, known as siRNAs (short interfering RNAs), can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials. Now, three new reports highlight the progress that researchers are making in developing broadly applicable, nanoparticle-enabled siRNA anticancer therapeutics.
According to press reports, U.S. District Judge Freda Wolfson ruled that Nicholas Purpura and Donald R. Laster Jr., who filed their lawsuit without a lawyer, lack legal standing to challenge the 2010 Patient Protection and Affordable Care Act.
A new analysis reveals that more than 90,000 new cancer cases a year in the United States may be due to physical inactivity and prolonged periods of sitting. The researchers presented their findings at the annual conference of the American Institute for Cancer Research (AICR) in Washington, D.C., citing about 49,000 cases of breast cancer and 43,000 of colon cancer from over 200 studies worldwide.
A Duke University-led study has found dangerously high levels of mercury and its more toxic chemical cousin, methylmercury, in soils, sediments and rivers near artisanal gold mines in the West African nation of Senegal.
Treating donor corneas with a cocktail of molecules prior to transplanting to a host may improve survival of grafts and, thus, outcomes in high-risk corneal transplant patients, according to a new study led by researchers at Massachusetts Eye and Ear.
› Verified 5 days ago